| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $7.1B | — |
| Cost of Revenue | $8.2B | $7.8B | $7.4B | $7.8B | $6.8B | $5.7B | $5.8B | — |
| Gross Profit | — | — | — | — | — | — | $0.5B | $0.5B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $1.0B | $1.0B | $0.9B | $1.0B | $0.9B | $0.9B | $0.7B | $0.7B |
| Operating Income | $1.7B | $2.0B | $1.7B | $1.5B | $1.0B | $0.6B | $0.7B | $0.8B |
| Net Income | $0.4B | $0.5B | $0.4B | $0.6B | $0.4B | $0.2B | $0.2B | $0.3B |
| EPS (Basic) | $4.62 | $4.67 | $4.15 | $5.67 | $3.06 | $1.57 | $1.43 | $2.10 |
| EPS (Diluted) | $4.58 | $4.63 | $4.11 | $5.63 | $3.02 | $1.55 | $1.41 | $2.08 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.5B | $13.4B | $12.5B | $12.3B | $11.5B | $11.1B | $10.8B | $10.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.3B | $1.3B | $1.3B | $1.3B | $1.6B | $1.4B | $1.3B | $1.2B |
| Total Liabilities | $6.2B | $5.7B | $5.7B | $6.3B | $6.2B | $6.1B | $5.7B | $5.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $8.3B | $7.7B | $6.8B | $6.0B | $5.3B | $4.9B | $5.1B | $4.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.0B | $1.3B | $1.0B | $1.3B | — | — | — |
| Investing Cash Flow | $-0.3B | $-0.2B | $-0.2B | $-0.2B | $-0.0B | — | — | — |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.8B | $-0.8B | $-1.2B | $-1.1B | $-1.0B | — | — | — |